Kathrin Schwager

1.3k total citations
17 papers, 1.0k citations indexed

About

Kathrin Schwager is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Immunology and Allergy. According to data from OpenAlex, Kathrin Schwager has authored 17 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Radiology, Nuclear Medicine and Imaging, 9 papers in Oncology and 7 papers in Immunology and Allergy. Recurrent topics in Kathrin Schwager's work include Monoclonal and Polyclonal Antibodies Research (11 papers), Cell Adhesion Molecules Research (7 papers) and CAR-T cell therapy research (4 papers). Kathrin Schwager is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (11 papers), Cell Adhesion Molecules Research (7 papers) and CAR-T cell therapy research (4 papers). Kathrin Schwager collaborates with scholars based in Switzerland, Italy and Germany. Kathrin Schwager's co-authors include Dario Neri, Eveline Trachsel, Manuela Kaspar, Katharina Frey, Teresa Hemmerle, Birgit Seelbach‐Goebel, A. Tschammler, David W. Hahn, German Ott and E. Paresce and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Kathrin Schwager

16 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kathrin Schwager Switzerland 14 487 482 375 301 123 17 1.0k
Bernard M. Tijink Netherlands 12 540 1.1× 424 0.9× 158 0.4× 333 1.1× 74 0.6× 24 1.1k
Christel Larbouret France 18 356 0.7× 652 1.4× 224 0.6× 366 1.2× 26 0.2× 36 971
Charlotte F. McDonagh United States 15 759 1.6× 790 1.6× 232 0.6× 517 1.7× 35 0.3× 41 1.2k
Thomas Hawthorne United States 20 226 0.5× 660 1.4× 421 1.1× 274 0.9× 58 0.5× 40 1.2k
M. I. Colnaghi Italy 15 402 0.8× 585 1.2× 273 0.7× 487 1.6× 71 0.6× 26 1.1k
Joo‐Hee Yi United States 9 525 1.1× 600 1.2× 97 0.3× 256 0.9× 38 0.3× 11 919
Elizabeth Crowley United States 16 244 0.5× 473 1.0× 172 0.5× 255 0.8× 60 0.5× 39 1.0k
David Egging Netherlands 14 322 0.7× 312 0.6× 85 0.2× 234 0.8× 96 0.8× 22 723
Lowell J. Underwood United States 12 122 0.3× 244 0.5× 212 0.6× 420 1.4× 120 1.0× 16 881
Thea M. Vroom Netherlands 19 141 0.3× 421 0.9× 217 0.6× 442 1.5× 209 1.7× 26 1.4k

Countries citing papers authored by Kathrin Schwager

Since Specialization
Citations

This map shows the geographic impact of Kathrin Schwager's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathrin Schwager with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathrin Schwager more than expected).

Fields of papers citing papers by Kathrin Schwager

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathrin Schwager. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathrin Schwager. The network helps show where Kathrin Schwager may publish in the future.

Co-authorship network of co-authors of Kathrin Schwager

This figure shows the co-authorship network connecting the top 25 collaborators of Kathrin Schwager. A scholar is included among the top collaborators of Kathrin Schwager based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathrin Schwager. Kathrin Schwager is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Schwager, Kathrin, Milton Waner, & Stephen T. Flock. (2015). In vivo Models for Studies of Laser Effects on Blood Vessels. Advances in oto-rhino-laryngology. 49. 5–7. 1 indexed citations
2.
Schwager, Kathrin, et al.. (2013). Murine analogues of etanercept and of F8-IL10 inhibit the progression of collagen-induced arthritis in the mouse. Arthritis Research & Therapy. 15(5). R138–R138. 37 indexed citations
3.
Moschetta, Michele, Francesca Pretto, Alexander Berndt, et al.. (2012). Paclitaxel Enhances Therapeutic Efficacy of the F8-IL2 Immunocytokine to EDA-Fibronectin–Positive Metastatic Human Melanoma Xenografts. Cancer Research. 72(7). 1814–1824. 78 indexed citations
4.
Schwager, Kathrin, Teresa Hemmerle, David Aebischer, & Dario Neri. (2012). The Immunocytokine L19–IL2 Eradicates Cancer When Used in Combination with CTLA-4 Blockade or with L19-TNF. Journal of Investigative Dermatology. 133(3). 751–758. 79 indexed citations
5.
Galeazzi, M., Caterina Baldi, Kathrin Schwager, et al.. (2012). FRI0194 A phase IB clinical trial with dekavil (F8-IL10), an anti-inflammatory immunocytokine for the treatment of rheumatoid arthritis, used in combination with methotrexate. Annals of the Rheumatic Diseases. 71. 378–378. 5 indexed citations
6.
Eigentler, Thomas, Benjamin Weide, Filippo de Braud, et al.. (2011). A Dose-Escalation and Signal-Generating Study of the Immunocytokine L19-IL2 in Combination with Dacarbazine for the Therapy of Patients with Metastatic Melanoma. Clinical Cancer Research. 17(24). 7732–7742. 125 indexed citations
7.
Schwager, Kathrin, et al.. (2011). A comparative immunofluorescence analysis of three clinical-stage antibodies in head and neck cancer. Head & Neck Oncology. 3(1). 25–25. 36 indexed citations
8.
Frey, Katharina, Kathrin Schwager, Benedetta Belloni, et al.. (2011). Different patterns of fibronectin and tenascin-C splice variants expression in primary and metastatic melanoma lesions. Experimental Dermatology. 20(8). 685–688. 51 indexed citations
9.
Bernardes, Gonçalo J. L., Giulio Casi, Sabrina Trüssel, et al.. (2011). A Traceless Vascular‐Targeting Antibody–Drug Conjugate for Cancer Therapy. Angewandte Chemie International Edition. 51(4). 941–944. 104 indexed citations
10.
Palumbo, Alessandro, Piotr Dziunycz, Kathrin Schwager, et al.. (2011). A chemically modified antibody mediates complete eradication of tumours by selective disruption of tumour blood vessels. British Journal of Cancer. 104(7). 1106–1115. 59 indexed citations
11.
Schwager, Kathrin, et al.. (2011). The antibody-mediated targeted delivery of interleukin-10 inhibits endometriosis in a syngeneic mouse model. Human Reproduction. 26(9). 2344–2352. 51 indexed citations
12.
Eigentler, Thomas, Benjamin Weide, Giosafat Spitaleri, et al.. (2011). A dose confirmation and signal-generating study of the immunocytokine L19-IL2 in combination with dacarbazine in patients with metastatic melanoma.. Journal of Clinical Oncology. 29(15_suppl). 2531–2531.
13.
Bernardes, Gonçalo J. L., Giulio Casi, Sabrina Trüssel, et al.. (2011). A Traceless Vascular‐Targeting Antibody–Drug Conjugate for Cancer Therapy. Angewandte Chemie. 124(4). 965–968. 18 indexed citations
14.
Frey, Katharina, et al.. (2011). Antibody-based targeting of interferon-alpha to the tumor neovasculature: a critical evaluation. Integrative Biology. 3(4). 468–478. 57 indexed citations
15.
Frey, Katharina, Christoph Schliemann, Kathrin Schwager, et al.. (2010). The Immunocytokine F8-IL2 Improves the Therapeutic Performance of Sunitinib in a Mouse Model of Renal Cell Carcinoma. The Journal of Urology. 184(6). 2540–2548. 56 indexed citations
16.
Schwager, Kathrin, Manuela Kaspar, Roberto Marcolongo, et al.. (2009). Preclinical characterization of DEKAVIL (F8-IL10), a novel clinical-stage immunocytokine which inhibits the progression of collagen-induced arthritis. Arthritis Research & Therapy. 11(5). R142–R142. 140 indexed citations
17.
Tschammler, A., et al.. (1998). Lymphadenopathy: differentiation of benign from malignant disease--color Doppler US assessment of intranodal angioarchitecture.. Radiology. 208(1). 117–123. 133 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bernard M. Tijink Breakdown of academic impact, for papers by Christel Larbouret Breakdown of academic impact, for papers by Charlotte F. McDonagh Breakdown of academic impact, for papers by Thomas Hawthorne Breakdown of academic impact, for papers by M. I. Colnaghi Breakdown of academic impact, for papers by Joo‐Hee Yi Breakdown of academic impact, for papers by Elizabeth Crowley Breakdown of academic impact, for papers by David Egging Breakdown of academic impact, for papers by Lowell J. Underwood Breakdown of academic impact, for papers by Thea M. Vroom
Rankless by CCL
2026